Jinling Pharmaceutical Company Limited (SHE:000919)
China
· Delayed Price · Currency is CNY 7.42
+0.04 (0.54%)
At close: Mar 10, 2026
SHE:000919 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 1,258 | 1,771 | 1,548 | 1,495 | 1,502 | 1,316 | Upgrade
|
| Short-Term Investments | 103.5 | 165.22 | 337.45 | 250 | - | - | Upgrade
|
| Trading Asset Securities | 1,198 | 706.05 | 233.86 | 92.35 | 1.25 | 1.38 | Upgrade
|
| Cash & Short-Term Investments | 2,560 | 2,642 | 2,119 | 1,837 | 1,503 | 1,317 | Upgrade
|
| Cash Growth | 21.51% | 24.69% | 15.33% | 22.25% | 14.12% | -16.44% | Upgrade
|
| Accounts Receivable | 694.77 | 686.73 | 591.05 | 467.22 | 507.2 | 488.79 | Upgrade
|
| Other Receivables | 7.07 | 8.16 | 8.76 | 53.12 | 16.85 | 6.38 | Upgrade
|
| Receivables | 701.84 | 694.89 | 599.81 | 520.34 | 524.05 | 495.17 | Upgrade
|
| Inventory | 267.15 | 271.62 | 290.91 | 250.48 | 245.48 | 215.44 | Upgrade
|
| Prepaid Expenses | - | - | 0.15 | 1.16 | - | 4.35 | Upgrade
|
| Other Current Assets | 15.39 | 9.37 | 9.63 | 23.79 | 16.29 | 15.13 | Upgrade
|
| Total Current Assets | 3,544 | 3,618 | 3,020 | 2,633 | 2,289 | 2,047 | Upgrade
|
| Property, Plant & Equipment | 1,484 | 1,501 | 1,541 | 1,303 | 1,297 | 1,307 | Upgrade
|
| Long-Term Investments | 60.63 | 431.07 | 369.32 | 265.01 | 638.97 | 674.37 | Upgrade
|
| Goodwill | 62.42 | 62.42 | 148.72 | 27.33 | 18.05 | 64.01 | Upgrade
|
| Other Intangible Assets | 322.87 | 325.67 | 341.67 | 258.44 | 140.2 | 148.18 | Upgrade
|
| Long-Term Deferred Tax Assets | 14.44 | 12.49 | 16.61 | 28.54 | 19.62 | 14.95 | Upgrade
|
| Long-Term Deferred Charges | 74.93 | 83.34 | 13.94 | 18.26 | 17.85 | 4.89 | Upgrade
|
| Other Long-Term Assets | 460.6 | 54.49 | 42 | 10.7 | 26.96 | 22.9 | Upgrade
|
| Total Assets | 6,024 | 6,089 | 5,493 | 4,544 | 4,448 | 4,284 | Upgrade
|
| Accounts Payable | 551.09 | 595.31 | 546.69 | 454.04 | 479.36 | 465.79 | Upgrade
|
| Accrued Expenses | 70.53 | 212.46 | 224.73 | 219.95 | 207.27 | 164.74 | Upgrade
|
| Short-Term Debt | - | - | - | 1.48 | 15.01 | - | Upgrade
|
| Current Portion of Leases | 2.77 | 4.23 | 3.08 | 1.53 | 1.06 | - | Upgrade
|
| Current Income Taxes Payable | 57.94 | 35.53 | 37.97 | 48.38 | 43.09 | 36.62 | Upgrade
|
| Current Unearned Revenue | 26.7 | 35.6 | 17.65 | 22.14 | 26.9 | 30.67 | Upgrade
|
| Other Current Liabilities | 251.64 | 143.9 | 182.53 | 117.9 | 83.25 | 101.75 | Upgrade
|
| Total Current Liabilities | 960.67 | 1,027 | 1,013 | 865.42 | 855.95 | 799.57 | Upgrade
|
| Long-Term Debt | 150.09 | 150.12 | - | - | - | - | Upgrade
|
| Long-Term Leases | 37.44 | 34.85 | 38.6 | 2.29 | 0.59 | - | Upgrade
|
| Long-Term Unearned Revenue | 0.76 | 1 | 0.47 | 0.63 | 0.79 | 1.27 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 27.94 | 27.28 | 28.72 | 48.98 | 55.77 | 49.58 | Upgrade
|
| Total Liabilities | 1,177 | 1,240 | 1,080 | 917.32 | 913.1 | 850.43 | Upgrade
|
| Common Stock | 621.92 | 623.71 | 511.14 | 510.4 | 504 | 504 | Upgrade
|
| Additional Paid-In Capital | 1,088 | 1,098 | 651.74 | 478.34 | 462.06 | 462.06 | Upgrade
|
| Retained Earnings | 2,082 | 2,073 | 2,095 | 2,025 | 1,958 | 1,888 | Upgrade
|
| Treasury Stock | - | -6.77 | -26.99 | -23.62 | - | - | Upgrade
|
| Comprehensive Income & Other | 0.24 | 3.09 | 3.42 | 4.17 | 3.29 | 3.29 | Upgrade
|
| Total Common Equity | 3,792 | 3,791 | 3,234 | 2,994 | 2,928 | 2,857 | Upgrade
|
| Minority Interest | 1,055 | 1,057 | 1,178 | 632.88 | 606.84 | 575.68 | Upgrade
|
| Shareholders' Equity | 4,847 | 4,849 | 4,412 | 3,627 | 3,535 | 3,433 | Upgrade
|
| Total Liabilities & Equity | 6,024 | 6,089 | 5,493 | 4,544 | 4,448 | 4,284 | Upgrade
|
| Total Debt | 190.29 | 189.21 | 41.67 | 5.3 | 16.66 | - | Upgrade
|
| Net Cash (Debt) | 2,369 | 2,453 | 2,077 | 1,832 | 1,486 | 1,317 | Upgrade
|
| Net Cash Growth | 12.68% | 18.08% | 13.39% | 23.26% | 12.85% | -16.44% | Upgrade
|
| Net Cash Per Share | 3.83 | 4.14 | 4.12 | 3.64 | 2.95 | 2.61 | Upgrade
|
| Filing Date Shares Outstanding | 621.92 | 623.71 | 629.06 | 488.88 | 510.4 | 504 | Upgrade
|
| Total Common Shares Outstanding | 621.92 | 623.71 | 511.14 | 488.88 | 504 | 504 | Upgrade
|
| Working Capital | 2,583 | 2,591 | 2,007 | 1,768 | 1,433 | 1,248 | Upgrade
|
| Book Value Per Share | 6.10 | 6.08 | 6.33 | 6.12 | 5.81 | 5.67 | Upgrade
|
| Tangible Book Value | 3,407 | 3,403 | 2,744 | 2,708 | 2,769 | 2,645 | Upgrade
|
| Tangible Book Value Per Share | 5.48 | 5.46 | 5.37 | 5.54 | 5.50 | 5.25 | Upgrade
|
| Buildings | - | 1,495 | 1,507 | 1,294 | 1,274 | 1,304 | Upgrade
|
| Machinery | - | 1,416 | 1,349 | 1,114 | 1,074 | 1,014 | Upgrade
|
| Construction In Progress | - | 71.78 | 84.2 | 37.84 | 28.78 | 16.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.